Publications by authors named "Upendra A Argikar"

Claim this Profile
B
Bioactivation and reactivity research advances-2024 year in review.
Joyce Liu, Upendra A Argikar, Pietro Brunetti, Maria Chatzopoulou, Luying Chen

Drug Metab Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug transporters in drug disposition - highlights from the year 2024.
Philip Sandoval, Pallabi Mitra, Upendra A Argikar, Masanori Nakakariya, Diane Ramsden

Drug Metab Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation research advances - 2024 year in review.
Lionel Cheruzel, Upendra A Argikar, Pietro Brunetti, Maria Chatzopoulou, Sungjoon Cho

Drug Metab Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of new drug modalities research advances - 2024 year in review.
Bin Ma, Upendra A Argikar, Luying Chen, Lionel Cheruzel, Sungjoon Cho

Drug Metab Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug transporters in drug disposition - highlights from the year 2023.
Paresh P Chothe, Upendra A Argikar, Pallabi Mitra, Masanori Nakakariya, Diane Ramsden

Drug Metab Rev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism of new drug modalities research advances - 2023 year in review.
Bin Ma, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Simon Hauri

Drug Metab Rev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2023 year in review.
Shuai Wang, Upendra A Argikar, Maria Chatzopoulou, Sungjoon Cho, Rachel D Crouch

Drug Metab Rev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation research advances - 2023 year in review.
S Cyrus Khojasteh, Upendra A Argikar, Maria Chatzopoulou, Lionel Cheruzel, Sungjoon Cho

Drug Metab Rev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Species-specific Bioactivation of Morpholines as a Causative of Drug Induced Liver Injury Observed in Monkeys.
Mithat Gunduz, Upendra A Argikar, Amanda L Cirello, Alan P Brown, Simone Bonazzi

Drug Metab Bioanal Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2022 year in review‡.
Shuai Wang, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D Crouch

Drug Metab Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation research advances - 2022 year in review.
S Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D Crouch

Drug Metab Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation novel advances - 2021 year in review.
S Cyrus Khojasteh, Upendra A Argikar, Sungjoon Cho, Rachel Crouch, Carley J S Heck

Drug Metab Rev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2021 year in review.
Klarissa D Jackson, Upendra A Argikar, Sungjoon Cho, Rachel D Crouch, James P Driscoll

Drug Metab Rev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel advances in biotransformation and bioactivation research - 2020 year in review.
S Cyrus Khojasteh, Upendra A Argikar, James P Driscoll, Carley J S Heck, Lloyd King

Drug Metab Rev· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).
Jin Zhou, Upendra A Argikar, John O Miners

Methods Mol Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Study 2: Practical Analytical Considerations for Conducting In Vitro Enzyme Kinetic Studies.
Upendra A Argikar, Swati Nagar

Methods Mol Biol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Proteomics Analysis of the Postmitochondrial Supernatant Fraction of Human Lens-Free Whole Eye and Liver.
Ankit Balhara, Abdul Basit, Upendra A Argikar, Jennifer L Dumouchel, Saranjit Singh

Drug Metab Dispos· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding metabolism related differences in ocular efficacy of MGV354.
Jennifer L Dumouchel, Upendra A Argikar, Christopher M Adams, Ganesh Prasanna, Takeru Ehara

Xenobiotica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-((2,4)-4-Ethoxy-1-((5-methoxy-7-methyl-1-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases.
Nello Mainolfi, Takeru Ehara, Rajeshri G Karki, Karen Anderson, Aengus Mac Sweeney, Upendra A Argikar

J Med Chem· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.
Mithat Gunduz, Upendra A Argikar, Amanda L Cirello, Jennifer L Dumouchel

Drug Metab Lett· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.
Rajeshri G Karki, James Powers, Nello Mainolfi, Karen Anderson, David B Belanger, Upendra A Argikar

J Med Chem· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
Anna Schubart, Karen Anderson, Nello Mainolfi, Holger Sellner, Takeru Ehara, Upendra A Argikar

Proc Natl Acad Sci U S A· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route.
Jennifer L Dumouchel, Nagendra Chemuturi, Mark N Milton, Gian Camenisch, James Chastain, Upendra A Argikar

Drug Metab Dispos· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saccharolactone: The History, the Myth, and the Practice.
Upendra A Argikar

Curr Drug Metab· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mesentery: an ADME perspective on a 'new' organ.
Aneesh A Argikar, Upendra A Argikar

Drug Metab Rev· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis